Autoimmune encephalopathy in Graves’ disease: remission after total thyroidectomy

G Gelosa
June 2009
Journal of Neurology, Neurosurgery & Psychiatry;Jun2009, Vol. 80 Issue 6, p698
Academic Journal
No abstract available.


Related Articles

  • Takotsubo Cardiomyopathy Complicating Thyroidectomy for Graves' Disease. Gundara, Justin S.; Lee, James C.; Ip, Julian; Sidhu, Stan B. // Thyroid;Sep2012, Vol. 22 Issue 9, p975 

    A letter to the editor is presented discussing a case of Takotsubo cardiomyopathy following total thyroidectomy for Graves' disease.

  • Graves' Disease that Developed Shortly after Surgery for Thyroid Cancer. Hea Min Yu; Soon Hyun Park; Jae Min Lee; Kang Seo Park // Endocrinology & Metabolism;Sep2013, Vol. 28 Issue 3, p226 

    Graves' disease is an autoimmune disorder that may present with various clinical manifestations of hyperthyroidism. Patients with Graves' disease have a greater number of thyroid nodules and a higher incidence of thyroid cancer compared with patients with normal thyroid activity. However, cases...

  • White Matter Alteration in a Patient With Graves' Disease. Kurne, Asli; Aydin, Ömer Faruk; Karabudak, Rana // Journal of Child Neurology;Sep2007, Vol. 22 Issue 9, p1128 

    A case of Graves' disease with white matter abnormalities is presented here. The diagnosis as Graves' disease was made when the patient was 5 years old, and a subtotal thyroidectomy was performed when she was 10. Her neurological symptoms began at age 19 with paresthesia of her legs and lower...

  • Hyperthyroidism in Childhood: Causes, When and How to Treat. Léger, Juliane; Carel, Jean Claude // Journal of Clinical Research in Pediatric Endocrinology;Mar2013 Supplement, Vol. 5, p50 

    Graves' disease (GD) is the most common cause of hyperthyroidism in children. This review gives an overview and update of management of GD. Antithyroid drugs (ATD) are recommended as the initial treatment, but the major problem is the high relapse rate (30%) as remission is achieved after a...

  • The efficacy and safety of total thyroidectomy in the management of benign thyroid disease: a review of 932 cases. Efremidou, Eleni I.; Papageorgiou, Mcihael S.; Liratzopoulos, Nikolaos; Manolas, Konstantinos J. // Canadian Journal of Surgery;Feb2009, Vol. 52 Issue 1, p39 

    Background: Total thyroidectomy is currently the preferred treatment for thyroid cancer, multinodular goitre and Graves disease; however, many surgeons choose not to perform total thyroidectomy to treat benign thyroid diseases owing to the associated risk of postoperative hypoparathyroidism and...

  • Total thyroidectomy safe, effective for Graves' disease. Ellis, Brian; Fisher, Stacey L.; Foster, Melissa; Kalvaitis, Katie; Sharer, Emily // Endocrine Today;Mar2011, Vol. 9 Issue 3, p51 

    The article discusses research done on the safety of total thyroidectomy for Graves' disease by J. Liu and colleagues, published in a 2011 issue of the "Journal of Surgical Research."

  • Postoperative Hypocalcemia After Thyroidectomy for Graves' Disease. Catherine E. Pesce; Zita Shiue; Hua-Ling Tsai; Christopher B. Umbricht; Ralph P. Tufano; Alan P.B. Dackiw; Jeanne Kowalski; Martha A. Zeiger // Thyroid;Nov2010, Vol. 20 Issue 11, p1279 

    Background:It is believed that patients who undergo thyroidectomy for Graves'' disease are more likely to experience postoperative hypocalcemia than patients undergoing total thyroidectomy for other indications. However, no study has directly compared these two groups of patients. The aim of...

  • Near total thyroidectomy is an optimal treatment for graves’ disease. Digonnet, Antoine; Willemse, Esther; Dekeyser, Cécile; Vandevelde, Luc; Michel, Moreau; Glinoer, Daniel; Larsimont, Denis; Andry, Guy // European Archives of Oto-Rhino-Laryngology;Jun2010, Vol. 267 Issue 6, p955 

    Surgical management of Graves’ disease is still debated. We report our current experience with thyroidectomy for Graves’ disease at a tertiary center. A retrospective database of 132 patients who underwent surgery for Graves’ disease from January 1985 to December 2008 was...

  • Erratum to: Thyroxine vs thyroxine plus triiodothyronine in treatment of hypothyroidism after thyroidectomy for Graves' disease. Bunevicius, Robertas; Jakuboniene, Neli; Jurkevicius, Renaldas; Cernicat, Jurate; Lašas, Liudvikas; Prange, Arthur // Endocrine (1355008X);Feb2014, Vol. 45 Issue 1, p161 

    A correction to the article "Thyroxine vs thyroxine plus triiodothyronine in treatment of hypothyroidism after thyroidectomy for Graves' disease" that was published in the March 9, 2013 issue of the journal is presented.

  • Hyperthyroidism: Current Treatment Guidelines. Gittoes, N.J.L.; Franklyn, J.A. // Drugs;Apr1998, Vol. 55 Issue 4, p543 

    Hyperthyroidism is common and affects approximately 2% of women and 0.2% of men. The most common cause of hyperthyroidism is Graves' disease, an autoimmune disorder associated with circulating immunoglobulins that bind to and stimulate the thyrotropin (TSH) receptor, resulting in sustained...


Read the Article


Sign out of this library

Other Topics